You can Check the U.S. business of AJU IB INVESTMEMT
Bellicum Pharmaceuticals Announces Closing of Initial Public Offering and Exercise of the Underwriters’ Option
Site : learn more
Apellis Pharmaceuticals Raises $33M to Fund its Complement Immunotherapy Programs
Site : learn more
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
Site : learn more
Grabbing a quick $55M venture round, Bellicum Pharma ponders an IPO
Site : learn more
Molecular Templates Announces Completion of $12M Series C Financing
Site : learn more
